Effectiveness and Safety of Fluticasone Propionate in Adolescents and Adults Who Have Asthma
- Study Title
- A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
- Teva Identifier
- FpS-AS-202 | 2010-023601-35
- ClinicalTrials.gov Identifier
- NCT01576718
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Fp MDPI | Other: Placebo MDPI | Drug: Flovent Diskus | Drug: albuterol/salbutamol
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 04/01/2012 - 10/01/2013
- Phase
- Phase 2
